ArticleCell death & disease2016

TC-N19, a novel dual inhibitor of EGFR and cMET, efficiently overcomes EGFR-TKI resistance in non-small-cell lung cancer cells.

D-W Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.